--:--:--LOCAL ·--:--UTC
    US EQUITIESLAST CLOSE
    AAPL$344.63-1.23%
    MSFT$521.91-1.55%
    GOOGL$279.84-1.40%
    AMZN$240.35-1.41%
    NVDA$204.64-4.22%
    META$614.99-1.53%
    TSLA$399.81-0.87%
    NFLX$62.08+0.05%
    BRK.B$542.49+0.10%
    AVGO$326.08-5.48%
    DIS$110.94+0.03%
    SBUX$103.67-1.74%
    MCD$258.12+0.29%
    NKE$38.67+0.65%
    COST$1012.28+1.63%
    WMT$123.51+1.86%
    HD$329.20+0.07%
    KO$94.08+1.36%
    PG$161.57+0.61%
    ORCL$130.67-6.37%
    CRM$229.17-0.75%
    ADBE$250.23+0.85%
    AMD$504.80-10.88%
    INTC$65.76-28.58%
    QCOM$164.79-11.12%
    CSCO$104.51-3.76%
    IBM$257.81-0.18%
    UBER$65.25-0.75%
    ABNB$164.39-1.24%
    SHOP$157.49-5.63%
    PYPL$57.01+0.11%
    COIN$143.54-10.62%
    PLTR$184.11-6.27%
    HOOD$84.99-7.21%
    JPM$337.04-1.90%
    V$413.59+0.74%
    MA$638.01+0.36%
    BAC$50.01-2.21%
    GS$894.55-3.58%
    LLY$1417.54+3.19%
    UNH$406.97-0.96%
    JNJ$273.20-0.73%
    PFE$30.52+1.90%
    XOM$187.25+2.16%
    BA$171.55-0.64%
    BABA$98.04-1.51%
    TSM$406.13-5.95%
    US EQUITIESLAST CLOSE
    AAPL$344.63-1.23%
    MSFT$521.91-1.55%
    GOOGL$279.84-1.40%
    AMZN$240.35-1.41%
    NVDA$204.64-4.22%
    META$614.99-1.53%
    TSLA$399.81-0.87%
    NFLX$62.08+0.05%
    BRK.B$542.49+0.10%
    AVGO$326.08-5.48%
    DIS$110.94+0.03%
    SBUX$103.67-1.74%
    MCD$258.12+0.29%
    NKE$38.67+0.65%
    COST$1012.28+1.63%
    WMT$123.51+1.86%
    HD$329.20+0.07%
    KO$94.08+1.36%
    PG$161.57+0.61%
    ORCL$130.67-6.37%
    CRM$229.17-0.75%
    ADBE$250.23+0.85%
    AMD$504.80-10.88%
    INTC$65.76-28.58%
    QCOM$164.79-11.12%
    CSCO$104.51-3.76%
    IBM$257.81-0.18%
    UBER$65.25-0.75%
    ABNB$164.39-1.24%
    SHOP$157.49-5.63%
    PYPL$57.01+0.11%
    COIN$143.54-10.62%
    PLTR$184.11-6.27%
    HOOD$84.99-7.21%
    JPM$337.04-1.90%
    V$413.59+0.74%
    MA$638.01+0.36%
    BAC$50.01-2.21%
    GS$894.55-3.58%
    LLY$1417.54+3.19%
    UNH$406.97-0.96%
    JNJ$273.20-0.73%
    PFE$30.52+1.90%
    XOM$187.25+2.16%
    BA$171.55-0.64%
    BABA$98.04-1.51%
    TSM$406.13-5.95%
    Plug stock market data into your AI agent — one command: Get your free API key →
    LoginGet API Key
    Company data coverage · ASX

    AVH — AVITA MEDICAL INC.

    Data coverage, completeness and provenance for AVITA MEDICAL INC. in the Stock Market API — Health Care · Medical Devices.

    ASX AUS
    Core-field completeness
    94.1%
    Statement periods
    FY2022–FY2025
    Filings archived
    0
    Price collection time
    2026-11-01 07:26 UTC

    Stored price coverage

    Source date: 2026-10-30T05:12:14. Source: yfinance. Collection time is shown separately and does not establish a trade date.

    Recent stored price bars, without investment interpretation
    DateCloseCurrencySourceAdjustment basis
    2026-10-304.6900AUDyfinanceSplit- and dividend-adjusted close
    2026-10-294.7100AUDyfinanceSplit- and dividend-adjusted close
    2026-10-284.5100AUDyfinanceSplit- and dividend-adjusted close
    2026-10-274.2500AUDyfinanceSplit- and dividend-adjusted close
    2026-10-264.3000AUDyfinanceSplit- and dividend-adjusted close

    GET /api/v1/companies/AVH/prices · Price parameters and adjustment semantics

    No archived filings are currently stored for this listing.

    Dataset availability · Handle missing data

    Profile

    AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions. It also provides RECALL autologous cell harvesting device, which can treat areas of up to 1,920 cm2; RECELL autologous cell harvesting device with ease-of-use, an enhanced ease-of-use device that can treat areas of up to 1,920 cm²; and RECELL GO mini autologous cell harvesting device, a line extension of the RECELL GO system to treat smaller wounds up to 480 cm2, as well as RECELL GO autologous cell harvesting device consisting of RECELL GO processing device, which controls and manages the pressure applied to disaggregate the donor skin cells and controls the incubation time of the RECELL Enzyme to optimize cell yield and promote cell viability; and RECELL GO preparation kit, which can treat areas up to 1,920 cm2. In addition, the company sells and distributes PermeaDerm, a biosynthetic wound matrix and Cohealyx, a collagen-based dermal matrix. It serves hospitals, treatment centers, and distributors. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical, Inc. in December 2020. AVITA Medical, Inc. is headquartered in Valencia, California.

    Employees: 226 · Website: https://avitamedical.com · Profile fields populated: 75%

    Data completeness by statement

    Share of stored fields populated in the anchor reporting period (FY2025), primary source yfinance. Full per-field breakdown: GET /api/v1/companies/AVH/financials.

    Income statement10/10 fields (100.0%)
    Balance sheet13/14 fields (92.9%)
    Cash flow5/6 fields (83.3%)
    Per-share3/4 fields (75.0%)

    Financial statement coverage (AUD)

    Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.

    PeriodPeriod end RevenueNet incomeTotal assetsTotal equity Fields populatedSource
    FY2025 (AUD) 2025-12-31 31 yfinance
    FY2024 (AUD) 2024-12-31 31 yfinance
    FY2023 (AUD) 2023-12-31 31 yfinance
    FY2022 (AUD) 2022-12-31 31 yfinance

    Get AVH data via the API

    The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.

    Company profile

    Name, sector, industry, HQ, employees, market cap, source-tagged.

    GET /api/v1/companies/AVH

    Financial statements

    Multi-year statements with per-field source tags and completeness.

    GET /api/v1/companies/AVH/financials

    Computed ratios

    P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.

    GET /api/v1/companies/AVH/metrics/summary

    News & announcements

    Dated press releases and announcements with source links.

    GET /api/v1/companies/AVH/news

    Quick start

    Create a free key, then:

    curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/AVH

    Query AVH programmatically

    Free tier — instant API key. Built for AI agents.

    Other ASX · Health Care companies covered

    Frequently Asked Questions

    What data does the API provide for AVH?
    Stored coverage for AVH: price data available, financial statements available, 0 archived filings. REST endpoints are under /api/v1/companies/AVH; inspect available source metadata for provenance.
    How complete is AVH's financial data?
    The anchor reporting period (FY2025) has 94.1% of the 17 core statement fields populated. Primary source: yfinance.
    What reporting periods are covered for AVH?
    4 fiscal-year periods are stored (FY2022–FY2025), with per-period field counts and source tags available via /api/v1/companies/AVH/financials.
    Where does AVH's data come from?
    Stored price source: yfinance. Primary source for the statement snapshot: yfinance. Inspect available period and field source tags at /api/v1/companies/AVH/financials; missing tags do not establish provenance.